Found 6 matching trials
A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS PHASE1 This is a Phase 1b, randomized, double-blind, placebo-controlled, dose rang...
Show More Location
Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM)
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia PHASE2 Hypoxic-ischemic encephalopathy (HIE) affects approximately 4,000 to 12,000...
Show More Learn More & Join Trial
A Phase 1 SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program PHASE1 This is a Phase 1, single-center, randomized, double-blind, placebo-control...
Show More Learn More & Join Trial
Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease PHASE2 This study is a Open Label Prospective Dose-Ranging Escalation and Expansio...
Show More Learn More & Join Trial
A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure PHASE1 The aim of this study will test the safety, tolerability, and efficacy of R...
Show More Location
Henry Ford Health Systems
Learn More & Join Trial
Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease PHASE2 AECOPD is a major cause of hospital admission and mortality. They contribut...
Show More Status
Active Not Recruiting
Learn More & Join Trial